$CLOV stock has now fallen 8% today, according to our price data from Polygon. There has been approximately $7,027,521 of trading volume.
It has been the 200th most-searched ticker on Quiver Quantitative over the last day, out of 11,571 total tickers searched.
Here is what we see in our data on $CLOV (you can track the company live on Quiver's $CLOV stock page):
$CLOV Insider Trading Activity
$CLOV insiders have traded $CLOV stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CLOV stock by insiders over the last 6 months:
- BRADY PATRICK PRIEST (CEO of Home Care) sold 175,000 shares for an estimated $379,750
- JAMIE L. REYNOSO (CEO, Medicare Advantage) has made 0 purchases and 7 sales selling 66,356 shares for an estimated $199,675.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CLOV Hedge Fund Activity
We have seen 80 institutional investors add shares of $CLOV stock to their portfolio, and 95 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RENAISSANCE TECHNOLOGIES LLC removed 3,221,559 shares (-41.8%) from their portfolio in Q4 2025, for an estimated $7,570,663
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 2,768,088 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,505,006
- BLACKROCK, INC. added 1,885,917 shares (+6.2%) to their portfolio in Q4 2025, for an estimated $4,431,904
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,878,719 shares (-70.7%) from their portfolio in Q4 2025, for an estimated $4,414,989
- DIMENSIONAL FUND ADVISORS LP added 1,494,043 shares (+69.8%) to their portfolio in Q4 2025, for an estimated $3,511,001
- JANE STREET GROUP, LLC removed 1,380,091 shares (-70.2%) from their portfolio in Q4 2025, for an estimated $3,243,213
- GMT CAPITAL CORP removed 1,305,200 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,067,220
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CLOV Analyst Ratings
Wall Street analysts have issued reports on $CLOV in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Canaccord Genuity issued a "Buy" rating on 11/06/2025
To track analyst ratings and price targets for $CLOV, check out Quiver Quantitative's $CLOV forecast page.
$CLOV Price Targets
Multiple analysts have issued price targets for $CLOV recently. We have seen 2 analysts offer price targets for $CLOV in the last 6 months, with a median target of $2.85.
Here are some recent targets:
- Richard Close from Canaccord Genuity set a target price of $3.2 on 03/20/2026
- Whit Mayo from Leerink Partners set a target price of $2.5 on 03/05/2026
You can track data on $CLOV on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
